Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Maitland, FL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Maitland, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Miami, FL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Miami, FL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
North Miami, FL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Oakland Park, FL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Oakland Park, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Orlando, FL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Tampa, FL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Study Site
mi
from
Atlanta, GA
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Study Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Augusta, GA
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Decatur, GA
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Study Site
mi
from
Chicago, IL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Oak Brook, IL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Oak Brook, IL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Shreveport, LA
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Worcester, MA
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Worcester, MA
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Flowood, MS
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Flowood, MS
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Creve Coeur, MO
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Kansas City, MO
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Las Vegas, NV
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Claremont, NH
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Claremont, NH
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Nashua, NH
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Nashua, NH
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Neptune, NJ
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Neptune, NJ
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Cedarhurst, NY
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Jamaica, NY
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Jamaica, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
New York, NY
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
New York, NY
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
New York, NY
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Rochester, NY
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Staten Island, NY
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Dayton, OH
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Oklahoma City, OK
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Scranton, PA
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Scranton, PA
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Study Site
mi
from
Austin, TX
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Study Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Dallas, TX
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Desoto, TX
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Desoto, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Bellevue, WA
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Burgas,
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Burgas,
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Fort Lauderdale, FL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Saint Louis, MO
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
Status: Enrolling
Updated:  3/8/2018
Prevention and Recovery Center for Early Psychosis (PARC)
mi
from
Indianapolis, IN
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
Status: Enrolling
Updated: 3/8/2018
Prevention and Recovery Center for Early Psychosis (PARC)
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
Status: Enrolling
Updated:  3/8/2018
Indiana University Psychotic Disorders Clinic
mi
from
Indianapolis, IN
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
Status: Enrolling
Updated: 3/8/2018
Indiana University Psychotic Disorders Clinic
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
Status: Enrolling
Updated:  3/9/2018
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
Status: Enrolling
Updated: 3/9/2018
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Folate Supplementation in Schizophrenia
Folate Supplementation in Schizophrenia
Status: Enrolling
Updated:  3/9/2018
Massachusetts General Hospital
mi
from
Boston, MA
Folate Supplementation in Schizophrenia
Folate Supplementation in Schizophrenia
Status: Enrolling
Updated: 3/9/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Status: Enrolling
Updated:  3/12/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Status: Enrolling
Updated: 3/12/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated:  3/12/2018
Medical College of Georgia
mi
from
Augusta, GA
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated: 3/12/2018
Medical College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated:  3/12/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated: 3/12/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated:  3/12/2018
West Central Behavioral Health
mi
from
Lebanon, NH
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated: 3/12/2018
West Central Behavioral Health
mi
from
Lebanon, NH
Click here to add this to my saved trials